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Stem cell phenotypes are reflected by posttranslational histone modifications, and this chromatin-related memory must be mi-
totically inherited to maintain cell identity through proliferative expansion. In human embryonic stem cells (hESCs), bivalent
genes with both activating (H3K4me3) and repressive (H3K27me3) histone modifications are essential to sustain pluripotency.
Yet, the molecular mechanisms by which this epigenetic landscape is transferred to progeny cells remain to be established. By
mapping genomic enrichment of H3K4me3/H3K27me3 in pure populations of hESCs in G2, mitotic, and G1 phases of the cell
cycle, we found striking variations in the levels of H3K4me3 through the G2-M-G1 transition. Analysis of a representative set of
bivalent genes revealed that chromatin modifiers involved in H3K4methylation/demethylation are recruited to bivalent gene
promoters in a cell cycle-dependent fashion. Interestingly, bivalent genes enriched with H3K4me3 exclusively during mitosis
undergo the strongest upregulation after induction of differentiation. Furthermore, the histone modification signature of genes
that remain bivalent in differentiated cells resolves into a cell cycle-independent pattern after lineage commitment. These results
establish a new dimension of chromatin regulation important in the maintenance of pluripotency.
Human embryonic stem cells (hESCs) are an increasingly pow-erful tool for regenerative medicine. They recapitulate, in
vitro, the molecular phenomena that take place during the first
stages of embryonic development. Like their in vivo counterparts,
ESCs proliferate rapidly and are able to form the three embryonic
germ layers (1). This highly self-renewing and pluripotent state is
sustained by a unique epigenetic landscape, consisting of tran-
scription factors, chromatin remodeling complexes, and histone
modifications that provide the transcriptional plasticity required
for rapid response to differentiation cues (2).
Histone H3 lysine 4 and 27 trimethylations (H3K4me3 and
H3K27me3, respectively) are key histone modifications that are
involved in transcriptional regulation (3, 4). H3K4me3 near tran-
scriptional start sites (TSSs) marks regions of active transcription
or transcriptional readiness (5). H3K27me3modification, in con-
trast, is a well-established negative regulator of gene expression
that repels transcriptional activators and attracts chromatin re-
pressors that promote chromatin compaction (6). Genomic re-
gions that host both histone marks, so-called bivalent domains,
were first observed in ESCs, primarily near promoters of genes
with developmental functions (7–9). Significant effort has gone
into understanding the biological role of bivalency; the consensus
is that, in ESCs, it represses transcription but poises genes for
rapid expression during lineage commitment (10). Although this
proposition is not yet supported with direct evidence, it has be-
come clear that bivalent domains are essential for maintaining
ESC pluripotency and self-renewing capacity (10). Despite the
extensive availability of genome-widemaps of these histonemarks
in pluripotent and committed cells, it is not understood how they
contribute to faithful reestablishment of transcriptional status af-
ter cell division. Compelling questions remain, including the de-
tailed localization of H3K4me3 and H3K27me3 during mitosis,
whether these histone marks are gained/lost exclusively during
mitosis, and perhaps more importantly, whether they constitute
bivalent domains that are retained after cells exit mitosis.
Here, we show that dynamic cell cycle control of H3K4 meth-
ylation/demethylation of bivalent genes represents a new dimen-
sion to chromatin regulation that advances understanding of how
the pluripotent histone modification landscape contributes to
maintenance of hESC identity. We developed a new method for
isolating pure populations of hESCs at theG2,mitosis (M), andG1
phases of the cell cycle and used these phase-specific populations
to map the genome-wide distribution of bivalent domains
(H3K4me3/H3K27me3) throughout the pluripotent cell cycle.
Consistent with a pivotal developmental function, we demon-
strate that bivalent genes enriched with H3K4me3 during mitosis
are maximally upregulated following induction of hESC differen-
tiation, and subsequently, H3K4me3 on these genes becomes cell
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cycle independent. Finally, we show that chromatin modifiers in-
volved in H3K4methylation/demethylation are recruited to biva-
lent gene promoters in a cell cycle-dependent fashion.
MATERIALS AND METHODS
hESC culture and differentiation. The H9 hESC line from WiCell Re-
search Institute (Madison,WI) wasmaintained on hESC-qualifiedMatri-
gel (BD Bioscience; catalog no. 354277) in mTeSR-1 medium (Stemcell
Technologies; catalog no. 05850) or essential E8 medium (Life Technol-
ogies; catalog no. A1517001), as recommended by the supplier. Cells were
expanded every 5 to 6 days, using nonenzymatic passaging according to
WiCell Research Institute standard protocols. To generate PAX6 cells,
undifferentiated ESCs were incubated in mTeSR-1 medium supple-
mented with 10 M retinoic acid (RA) (Sigma-Aldrich; catalog no.
R2625-50MG) for 5 days. The treatment started 1 day after plating of the
cells, andmediumwas changed every day. hESC researchwas approved by
the Institutional Embryonic Stem Cell Research Oversight Committee at
the University of Vermont.
Cell sorting.Pure populations of cells at theG2,mitosis, orG1 phase of
the cell cycle were isolated by fluorescence-activated cell sorting (FACS),
taking advantage of differences in DNA content to distinguish cells in
G2/M from cells in G1 and the exclusive presence of histone H3 serine 28
phosphorylation (H3S28p) in mitosis to discriminate cells in G2 from
those in M phase (Fig. 1A and C). As indicated in the figure legends, both
nocodazole-synchronized and untreated cells were sorted using the pro-
cedure described here. After fixation, cells were permeabilized for 10 min
using a mild permeabilization/wash buffer containing saponin (BD Bio-
science; catalog no. 51-2091KZ). For ESC isolation, cells were incubated
with labeled antibodies to OCT4 (phycoerythrin [PE] conjugated; BD
Bioscience; catalog no. 561556) andH3S28p (Alexa Fluor 647 conjugated;
BD Bioscience; catalog no. 558609) for 30 min. Labeled antibodies to
PAX6, instead of OCT4 (PE conjugated; BD Bioscience; catalog no.
561552) were used to stain PAX6 cells. After staining, cells were washed
with permeabilization/wash buffer, resuspended in 2% fetal bovine serum
(FBS) in phosphate-buffered saline (PBS), and counterstained with 1
g/ml 4=,6-diamidino-2-phenylindole (DAPI) (Life Technologies; cata-
log no. D1306) for 30min. FACSwas performed on a BD FACSAria II cell
sorter using linear forward scatter (FSC) and side scatter (SSC) scaling,
followed by height- and area-based doublet discrimination. Compensa-
tion was calculated using FACS Diva autocompensation algorithms and
supplemented by manual compensation to correct for autofluorescence.
Cells with subnormal DNA content were filtered out during the gating,
and only sampleswith a purity of 95%or higherwere used in the following
experiments.
Synchronization of hESCs. Before every cell sorting experiment, cells
were allowed to establish robust colonies. Normally, they were collected 4
to 5 days after plating. To improve the cell yield from sorting, in some
experiments we synchronized hESCs at either the G2/M orG1 phase of the
cell cycle 1 day before the collection, by incubation with nocodazole (Sig-
ma-Aldrich; catalog no.M1404-2MG) (200 ng/ml for 16 hwhen cells were
grown inmTeSR-1). Blocking of hESCs inG2/Mphase was reversible, and
cells resumed the cell cycle and progressed into G1 after nocodazole was
withdrawn from the culturemedium. For cells growing in E8medium, 25
ng/ml of nocodazole for 16 h was enough to block most of the cells in
G2/M and allowed progression into G1 after nocodazole was withdrawn
from the medium (data not shown). After synchronization, cells were
collected as single cells by treatment with Acutase (MP Biomedicals; cat-
alog no. 1000449) and subsequently fixed with 1% formaldehyde for 10
FIG 1 Genome-wide mapping of H3K4me3 and H3K27me3 across the cell cycle reveals a highly dynamic landscape of bivalent genes in hESCs. (A) Immuno-
fluorescence microscopy of unsynchronized hESCs showing DNA (DAPI, blue), OCT4 (red), and H3S28p (green). (B) FACS gating parameters used to sort
nocodazole-synchronized hESCs into three populations: G2, mitosis (M), and G1. (C)Western blot analysis of cell cycle markers H3S28p, H3S10p, and CDT1 in
hESCs during nocodazole block (16 h) and 1 h after nocodazole release (1 h) and synchronized cells sorted into G2, M, and G1 phases of the cell cycle. Tubulin
and total H3 were used as loading controls. (D) Aggregation plots of mean enrichment signal densities for H3K27me3 and H3K4me3. Themean signal densities
atG2,M, andG1 phases are centered on regionswithin 2 kb upstreamor downstreamof TSSs. ChIP-seq enrichment/input in a log2 scale is displayed. (E)GO term
analysis of genes enriched for both H3K27me3 and H3K4me3 during the cell cycle. The percentage of bivalent genes that are represented in each GO term
category is also displayed (% Genes).
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min followed by 5 min of incubation with 0.125 M glycine (Sigma-Al-
drich; catalog no. G8790-100G). Cells were counted and stored at80°C.
Immunofluorescencemicroscopy.H9 cells were grown on coverslips
previously coated with hESC-qualified Matrigel (BD Bioscience; catalog
no. 354277). Normally, 3 days after plating, cells were fixedwith 1% form-
aldehyde in PBS for 10 min and processed for immunofluorescence. For
PAX6 cells, the fixation was performed at the end of the differentiation
protocol. Subsequently, cells were permeabilized in 0.25% Triton X-100
in PBS and blocked with 0.5% bovine serum albumin (BSA) in PBS. Cells
were stained with the following antibodies for 1 h at room temperature:
anti-OCT4 (Abcam; catalog no. ab1857 [1:2,000]; Santa Cruz Biotechnol-
ogy; catalog no. sc8628 [1:1,000]), anti-H3S28p (Millipore; catalog no.
07-145 [1:5,000]), or anti-PAX6 (Santa Cruz Biotechnology; catalog no.
sc81649 [1:1,000]). Nuclear DNAwas counterstained with DAPI (0.1g/
ml). Secondary antibodies conjugatedwithAlexa Fluor 594 orAlexa Fluor
488 (1:1,000; Molecular Probes/Invitrogen) were incubated for 1 h in a
humidity chamber and at room temperature. Finally, cells were mounted
in Prolong-Gold (Invitrogen).
Immunofluorescence analysis for cells in suspension.After cell sort-
ing experiments, the purity of the sorted samples was evaluated by immu-
nofluorescence analysis. Briefly, a small aliquot of sorted cells was spun
down on coverslips by using Cytospin4 (Thermo Shandon). Subse-
quently, cells were stained using the standard immunofluorescence pro-
tocol. Anti-Ki67 antibody was used in these experiments (Santa Cruz
Biotechnology; catalog no. sc23900).
Immunoblotting. Whole-cell extracts from cell cycle-specific or un-
synchronized cells were used to analyze protein expression by Western
blotting. The following antibodies were used: anti-H3 (Abcam; catalog
no. ab1791 [1:5,000]), anti-H3S28p (Millipore; catalog no. 07-145 [1:
5,000]), anti-H3S10p (Upstate; catalog no. 05-598 [1:5,000]), anti-CDT1
(Abcam; catalog no. ab70829 [1:2,000]), antitubulin (Sigma; catalog no.
T9026 [1:30,000]), anti-EZH2 (Cell Signaling; catalog no. AC22 [1:
1,000]), anti-MLL-C (antiserum [1:1,000]), anti-KDM1 (Abcam; catalog
no. ab17721 [1:1,000]), anti-KDM5A (Abcam; catalog no. ab70892 [1:
1,000]), and anti-KDM5B (Abcam; catalog no. ab56759 [1:5,000]).
Chromatin immunoprecipitation-quantitative PCR (ChIP-qPCR)
assays. Cells at specific phases of the cell cycle, obtained from 3 to 4
different cell sorting experiments, were pooled and treated as a single
sample (or biological replicate). Cells were washed twice with PBS and
subjected to extraction of nuclei according to the method in reference 11
withmodifications. Isolated nuclei were sonicated using aMisonix S-4000
ultrasonic processor (QSonica) to obtain sheared chromatin ranging
from 0.2 to 0.6 kb in size. Five hundred nanograms of sheared chromatin
was immunoprecipitated overnight at 4°C. Immunoprecipitated com-
plexes were purified using protein G Dynabeads (Invitrogen), washed
three times with low-salt buffer (0.1% SDS, 1% Triton X-100, 2 mM
EDTA, 20mMTris-HCl, pH 8, 150mMNaCl), once with high-salt buffer
(0.1% SDS, 1% Triton X-100, 2 mM EDTA, 20 mM Tris-HCl, pH 8, 500
mM NaCl), once with Tris-EDTA (TE)–NaCl buffer (1 mM EDTA, 10
mMTris-HCl, pH 8, 50mMNaCl), and subsequently eluted (SDS 1%, 0.1
MNaHCO3), reverse cross-linked, and quantified by qPCR using specific
primers. The following are antibodies used in this assay: anti-
H3K4me3 (Abcam; catalog no. ab1012), anti-histone H3 (Abcam; cat-
alog no. ab1791, lot no. GR151029-1), anti-KDM5A (Abcam; catalog
no. ab70892, lot no. GR70517-14/GR70517-24), anti-WDR5 (Abcam;
catalog no. ab56919, lot no. GR186228), anti-MLL1-473 (kindly do-
nated by Eli Canaani, Weizmann Institute, Israel), anti-MLL2 (Bethyl
Laboratories Inc.; catalog no. A300-113A). Primers included
PPP1R1A-F (TCCTTCGGTCAGTCTCAAAG), PPP1R1A-R (GAC
GAACGCTCAGTTTGC), TBX1-F (ATAGGGCGCTGTAAGCAAC),
TBX1-R (AAAGGGAAGCACTGAGGAG), TLX2-F (TAGCGGGACT
CACCTTCC), TLX2-R (GGAGACGGGGTCAGAGTC), TBC1D20-F
(GTAATTACATCGGCGGTACG), TBC1D20-R (GGTATCAGCTCTCCC
GAAC), COL1A1-F (TCATCATCTCCCTTCCATTC), COL1A1-R (TAC
TCTATATCGCGCCTTGC), FOXJ1-F (AGCTGGGGAGGATCTTTT
AG), FOXJ1-R (ACCTCGAAGAGGAAAGGAAG), PAX6-F (CTCCAGCA
AAACACTTCCTC), PAX6-R (CGGAGTGATTAGTGGGTTTG), CDC25A-
prox-F (TGCTCTTCGCCTGCAGCCC), CDC25A-prox-R (CTCTCCG
AGGCCGACACCGA), CDC25A-dist-F (ACAGTGGGACCACAGACCA
TGTG), CDC25A-dist-R (AGCCATGCTGGACAGGTGGA), HOXA4-F
(TCTAGGCTAACAGGCGAAAG), and HOXA4-R (GATCTGCGGTTG
AGAAAATG).
Chromatin immunoprecipitation sequencing (ChIP-seq) library
preparation.Cells at specific phases of the cell cycle, obtained from 3 to 4
different cell sorting runs, were pooled and treated as a single sample (or
biological replicate). Two biological replicates were analyzed for each cell
cycle phase and for each cellular condition (ESCs and PAX6 cells). Cells
were washed twice with PBS and subjected to extraction of nuclei accord-
ing to themethod in reference 11 withmodifications. Isolated nuclei were
sonicated using a Misonix S-4000 ultrasonic processor (QSonica) to ob-
tain sheared chromatin ranging from 0.2 to 0.6 kb in size (see Fig. S2A in
the supplemental material). Sheared chromatin (4 g) was immunopre-
cipitated with either anti-H3K4me3 (Abcam; catalog no. ab1012) or anti-
H3K27me3 (Millipore; catalog no. 07-449). Immunoprecipitated com-
plexes were purified using protein G Dynabeads (Invitrogen), eluted,
reverse cross-linked, quantified, and subjected to library preparation. Im-
munoprecipitated DNA or input DNA for each cell cycle phase, cellular
condition (ESC versus PAX6 cells), and biological replicate was end re-
paired using the End-It DNA end repair kit (Epicentre), extended using a
Klenow fragment (3=-5= exo) (Epicentre), and ligated to sequencing adap-
tor oligonucleotides (Illumina), according to the manufacturers’ recom-
mendations. Each library was then subjected to 15 cycles of PCR amplifi-
cation using PFU Ultra II Hotstart master mix (Agilent) and size selected
in the range of 300 50 bp. The final libraries were quantified using both
Qubit fluorimeter (Life Technologies) and Bioanalyzer (Agilent Technol-
ogies) systems and then submitted for sequencing.
ChIP-seq analysis. Single-end 36-base sequencing was performed on
an Illumina Genome Analyzer II. Base calls and sequence reads were gen-
erated using Illumina CASAVA software (version 1.6; Illumina). Reads
were mapped to the human genome (GRCh37, hg19) using bowtie (ver-
sion 0.12.8) (12) with up to two mismatches allowed. For each cellular
condition (i.e., defined by cell cycle phase and differentiation state), ge-
nome-wide enrichment profiles were generated from pooled ChIP-seq
replicates versus input for H3K27me3 and H3K4me3, respectively, using
SPP (13). The resulting enrichment profiles are conservative statistical
estimates of log2 fold enrichment across the genome, corresponding to a
99% confidence interval,   0.01. The UCSC known gene annotations
(14) for canonical transcripts were used to analyze enrichments around
transcriptional start sites (TSSs). In order to restrict our analysis to genes
enriched for both H3K27me3 andH3K4me3, so-called bivalent genes, we
required that for both histone modifications during any pair of cell cycle
phases, minlog2e1
j , log2e2
j , · · ·, log2ei
j, · · ·, log2eN
j   1, where ei
j is
the enrichment at the ith position around the TSS for gene j and N is
chosen such that the window within size is 500 bp. That is, bivalent genes
were defined to show a 2-fold or greater enrichment everywhere in at least
one 500-bp window of the spanned TSS neighborhood (within 2 kb up-
stream or downstream of the TSS). This restriction resulted in 5,240 bi-
valent genes. These bivalent genes were examined by direct inspection of
the relative H3K4me3 enrichments between different phases of the cell
cycle and also using k-means clustering. For the relativeH3K4me3 enrich-
ments, the mean ratio of M-phase to G2-phase or M-phase to G1-phase
enrichments for gene j was calculated as, for example, [log2(M/G2)] 
[log2(M)]  [log2(G2)], where log2M  
1
N
iN⁄2
N⁄2 log2ei
j,M and
N= was chosen to bracket the TSS by 1 kb upstream and downstream.
Functional enrichment analysis for the genes grouped by ChIP-seq en-
richment patterns used DAVID v. 6.7 (15, 16).
RNA-seq sample preparation. Total RNAs from undifferentiated H9
cells or PAX6 cells were isolated by using TRIzol (Invitrogen). Subse-
quently, we removed DNA contaminants using a DNA-free RNA extrac-
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tion kit (Zymo Research). According to Illumina’s recommended proto-
col, 2 g of DNA-free total RNA was used to construct each paired-end
transcriptome sequencing (RNA-seq) library with the TruSeq RNA sam-
ple preparation kit v2 (Illumina). Libraries were subjected to 15 cycles of
amplification with pair-end PCR primers (Illumina). Libraries were
quantified using a Bioanalyzer system and sequenced on the HiSeq-1000
platform (Illumina) for the read length of 100 bases. To address the influ-
ence of culture medium on RNA expression, RNA-seq libraries were built
from stocks of ESCs maintained in either mTeSR-1 or essential E8 me-
dium. The RNA-seq libraries for PAX6 cells were generated from original
cellular stocks maintained in either mTeSR-1 or E8 medium. No major
differences in RNA expression were detected among different stocks.
Therefore, libraries of similar cellular condition (control or differenti-
ated) were considered biological replicates.
RNA-seq analysis. Raw sequences from RNA-seq libraries were
mapped to genome assembly hg19 using TopHat (version 2.0.8b) (17)
with parameters “-b2-sensitive -r 80 -g 10.” Mapped reads were analyzed
using SeqMonk software (v0.27.0; Babraham Bioinformatics Institute).
Expression profiles were calculated using the RNA-seq quantitation pipe-
line and normalized by globally adjusting count distributions at the 75th
percentile. Differential expression was calculated using the intensity dif-
ference statistical test included in the software. Differential expressionwas
called on log2-transformed counts by selecting transcripts that changed
with a significance (P) of0.05 after Benjamini andHochberg correction
using a null model constructed from the 1% of transcripts showing the
closest average level of observation to estimate experimental noise. Scatter
plots were made using CummeRbund and customized R scripts. Similar
results were obtained using Cuffdiff (version 2.1.1).
Inhibition of MLL1/2 proteins in hESCs. H9 cells were grown on
hESC-qualified Matrigel (BD Bioscience; catalog no. 354277) in essential
E8 medium (Life Technologies; catalog no. A1517001), as recommended
by the supplier. After plating (2 days), the cells were preincubated in
mTeSR-1medium supplemented with a cocktail of MLL inhibitors (MLL
inh): Mi-2 (Selleckchem; catalog no. S7618) plus MM-102 (Selleckchem;
catalog no. S7265), 20Meach (MLL inh). Control cells were treatedwith
dimethyl sulfoxide (DMSO) only (ATCC; 4). Eight hours later, cells
were exposed to DMSO, nocodazole (200 ng/ml), or nocodazole plus
MLL inh, for another 16 h. Subsequently, cells were washed twice with
Versene (0.02% EDTA; Lonza; catalog no. 17-711E) and incubated for 10
min in Versene at 37°C, to obtain single cells. Cells were fixed with 1%
formaldehyde, counted, and processed for ChIP assays, as described un-
der “Chromatin immunoprecipitation-quantitative PCR (ChIP-qPCR)
assays.”
For RNA expression assays, the protocol was slightly different. Cells
were incubated in mTeSR-1 containing either DMSO or MLL inhibitors
for 24 h. Afterward, cells were rinsed twicewithVersene and incubated for
10 min in Versene at 37°C, to obtain single cells. Then, cell suspensions
were washed twice with fresh essential E6 medium (Life Technologies;
catalog no. A1516401) and counted. Cells were seeded at a density of
800,000 cells/well in 6-well plates coated with Matrigel, in essential E6
medium containing retinoic acid (1 M). Twenty-four hours later, cells
were processed for RNA isolation using TRIzol (Invitrogen). Total RNA
(1 g) was used to synthesize cDNA using the SuperScript III reverse
transcriptase cDNA synthesis kit (Life Technologies; catalog no.
18064-014). Gene expression was quantified by qPCR using specific
primers: PAX6-F (CTTTGCTTGGGAAATCCGAG), PAX6-R (AGCC
AGGTTGCGAAGAACTC), HOXA4-F (GCAAGGAGCCCGTGGTG
TA), HOXA4-R (GTTGGGCAGTTTGTGGTCTTT), GATA6-F (GCA
AAAATACTTCCCCCACA), GATA6-R (CGCCTATGTAGAGCCCA
TCT), MEIS2-F (AAGGGGGAAGTTTGCAGAGC), MEIS2-R (AATG
CATTGGGGGTCCATGT), NANOG-F (CATGAGTGTGGATCCAG
CTTG), NANOG-R (CCTGAATAAGCAGATCCATGG), OCT4-F (A
GTGAGAGGCAACCTGGAGA), OCT4-R (ACACTCGGACCACATC
CTTC), MIXL1-F (GGTACCCCGACATCCACTTG), MIXL1-R (TAA
TCTCCGGCCTAGCCAAA), SIP1-F (CGCTTGACATCACTGAAG
GA), SIP1-R (CTTGCCACACTCTGTGCATT), GAPDH-F (ATGTTC
GTCATGGGTGTGAA), and GAPDH-R (TGTGGTCATGAGTCCTT
CCA).
Accessionnumber.TheGene ExpressionOmnibus accession number
for the ChIP-seq and RNA-seq data reported in this paper is GSE55502.
RESULTS
Genome-widemapping ofH3K4me3 andH3K27me3 across the
cell cycle inhESCs reveals that thebivalenthistonemodification
landscape is highly dynamic. To gain insights into the mecha-
nisms that control themitotic inheritance of bivalency in pluripo-
tent cells, we globally mapped the genomic locations of the
H3K4me3 and H3K27me3 modifications in pure populations of
hESCs at the G2, M, or G1 phase of the cell cycle, by chromatin
immunoprecipitation coupled to high-throughput sequencing
(ChIP-seq). To this end, OCT4	 hESCs at G2, M, or G1 were
isolated by fluorescence-activated cell sorting (FACS), based on
both DNA content and H3S28p (histone H3 phosphorylated at
serine 28), a mitosis-specific epigenetic mark (18) (Fig. 1A to C).
We enriched cultures for mitotic cells by treating them with no-
codazole (200 ng/ml, 16 h), awidely used synchronizing agent that
has been successfully employed to synchronize ESCs (19–22).
Cells in G1 were purified 1 h after release of the nocodazole block.
The sorted cells exhibited the expected cell cycle-dependent
morphological and molecular characteristics (see Fig. S1A in the
supplemental material). M-phase cells displayed condensed chro-
mosomes and relatively dispersed OCT4 distribution. G1 cells
were the smallest and exhibited the typical micropunctate pattern
for the Ki67 protein (19). G2 cells were larger than G1 cells and
displayed one or two large Ki67 foci. Biochemical analysis (Fig.
1C) confirmed that H3S28p was exclusive tomitosis (18) and that
the licensing factor CDT1 reaches its minimum protein levels in
G2 and its maximum during mitosis (23). Importantly, the pro-
tein levels of the pluripotencymarkers OCT4 and SSEA4 were not
affected by the nocodazole treatment (see Fig. S1B). These analy-
ses demonstrate that our strategy yields highly pure populations of
hESCs at the G2, mitosis, or G1 phase of the cell cycle that are
suitable for genome-wide analysis.
Bivalent domains are typically located at gene promoters, and
the vast majority of the H3K27me3 modifications observed in
ESCs are found in these regions (7, 8). Therefore, we used the
more than 15 million uniquely mapped reads generated for each
histone mark and cellular condition, to calculate conservative ge-
nome-wide ChIP-seq enrichments within regions centered at the
canonical TSS (kb 2) of the UCSC-known genes (Spearman
correlations between biological replicates, 0.84 to 0.98 [see Fig.
S2E and F in the supplemental material]). We found that about
one-third (5,340) of the 17,002 genesmodified byH3K4me3 were
comodified by H3K27me3. Consistent with previous reports, this
group was enriched in genes with developmental functions (Fig.
1E) (7–9). Importantly, themajority of these genes (
3,000) have
been previously classified as bivalent in hESCs (24) (see Fig. S2C).
The additional 2,154 genes classified as bivalent in our study are
also enriched in developmental functions and, on average, dis-
playedH3K4me3/H3K27me3 enrichment comparable to that ob-
served in “established” bivalent genes (see Fig. S2B to D). In gen-
eral, the enrichment profiles of bivalent genes at G2, M, and G1
phases of the cell cycle displayed the narrow peak-like distribution
typical for H3K4me3 and the broader domain-like configuration
associated with H3K27me3 (Fig. 1D) (8, 9).
Grandy et al.
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Interestingly, H3K4me3 levels showed striking variations
throughout the cell cycle, reaching maximum enrichment during
mitosis and minimum enrichment in G1 (Fig. 1D): comparing
these enrichments, normalized using an MA-norm-like proce-
dure (see below) and averaged over a region within 2 kb upstream
or downstream of each TSS, across these three cell cycle phases
using Tukey’s range test showed that the means differed with a P
value of7 105. This result correlates well with immunoflu-
orescence analysis showing that there are foci with enhanced
H3K4me3 signal during mitosis, compared with cells in inter-
phase (see Fig. S2G in the supplemental material).
In contrast, H3K27me3 levels remained relatively constant across
the G2-M-G1 transition (Fig. 1D): comparing these enrichments,
normalizedusing anMA-norm-like procedure (see below) and aver-
aged over a regionwithin 2 kb upstreamor downstreamof each TSS,
across these three cell cycle phases using Tukey’s range test showed
that themeans differed relatively little, with a P value of0.09. Con-
sistently, immunofluorescence assays showed no differences in
H3K27me3 levels betweenmitotic and interphase cells (see Fig. S2H
in the supplemental material). Overall, these results indicate that
H3K27me3 is stable across the cell cycle, suggesting that this histone
mark differs from H3K4me3 not only in its relationship with tran-
scription but also in its regulation throughout the cell cycle.
Cell cycle-dependent changes in H3K4me3modification de-
fine new classes of bivalent genes. Motivated by repeated obser-
vations of genes enriched with H3K4me3 during mitosis (mitosis
enriched [ME]), genes that exhibited constant levels of H3K4me3
in G2 and M followed by a pronounced drop during G1 (G1 de-
pleted [G1-dep]), and genes that maintained relatively stable
H3K4me3 levels across the cell cycle (ubiquitous [Ub]) (Fig. 2A;
see also Fig. S3C in the supplemental material), we classified the
bivalent genes into these three categories by defining threshold
values for the relevant ratios of mean enrichments (see Materials
andMethods and Fig. S3B for details). In this straightforwardway,
we identified 690ME genes with levels of H3K4me3 modification
at least 2-fold higher duringmitosis than in G2 or G1, including 28
genes that were manually reassigned based on their histone mod-
ification profiles (see Table S1). We found 2,665 G1-dep genes
with similar levels of H3K4me3 in mitosis and G2 and at least
2-fold-lower levels during G1 and 1,886 Ub genes with relatively
constant levels ofH3K4me3 across the cell cycle (Fig. 2B andC; see
also Fig. S3C). As an alternative means of classifying cell cycle-
dependent H3K4me3 enrichments, k-means clustering (k  3)
was applied to the enrichment profiles, after normalizing the
ChIP-seq data by either read counts (25) or an MA-norm-like
scaling in which linear scaling is used to ensure that the average
ChIP-seq enrichment across different cellular conditions is equal
over the set of common peaks (26) (see below and Fig. 4D). It is
important to note the consistency with which these three cell cy-
cle-dependent signatures were observed, indicating that these his-
FIG 2 Cell cycle-dependent changes in H3K4me3 define new classes of bivalent genes. (A) ChIP-seq enrichment at select bivalent genes from each of the three
cell cycle-dependent bivalency profiles. Shaded areas indicate bivalent domains. ChIP-seq enrichments/input in a log2 scale are displayed. (B) Heat map of
H3K27me3 and H3K4me3 profiles over 4,000-bp regions spanning the TSSs of UCSC canonical genes, grouped according to the divisions illustrated in Fig. S3B
in the supplemental material: mitosis enriched (top), G1 depleted (middle), and ubiquitous (bottom). The total number of genes clustered into each group is
displayed on the right. (C) Aggregation plots of H3K4me3 andH3K27me3ChIP-seq enrichments for bivalent genes clustered according to panel B. (D)GO term
analyses of the three groups of bivalent genes clustered by H3K4me3 enrichment profiling. Tables display randomly selected genes from each cluster. (E)
ChIP-qPCR analysis of H3K4me3 in hESCs sorted at specific phases of the cell cycle without prior chemical synchronization. Results (n 3) were normalized
by total histone H3 levels and expressed as percent input. Ordinary one-way analysis of variance followed by Tukey’s test for multiple comparisons was
performed. *, P 102; ***, P 104; ****, P 105; ns, not significant.
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tone modification patterns are robust; the same pattern emerges
regardless of the data processing method. Throughout the re-
mainder of this paper, the gene classification fromFig. S3B is used.
A more in-depth examination revealed that the ME category
includes bivalent genes with the highest levels ofH3K27me3mod-
ification (Fig. 2C; see also Fig. S4B in the supplemental material),
and gene ontology (GO) analysis revealed that developmentally
relevant transcription factor genes are overrepresented in this
group (Fig. 2D). Of note, many of these transcription factor genes
were marked with H3K4me3 only during mitosis, suggesting
stringent cell cycle control of this histonemark (Fig. 2A,D, and E).
The Ub and G1-dep categories displayed comparable average lev-
els of H3K27me3 across the cell cycle (Fig. 2C; see also Fig. S4B),
and both include many genes involved in membrane biology and
cell signaling; however, the G1-depleted group uniquely includes
genes implicated in phosphorylation processes (Fig. 2D). Overall,
these observations suggest a functional separation of genes asso-
ciated with these three bivalency profiles. Interestingly, we ob-
served genomic regions in which two different cell cycle-depen-
dent bivalency patterns are separated by only a few kilobases (Fig.
2A; see also Fig. S3A). This finding further supports the notion
that bivalency is strictly regulated and molecularly compartmen-
talized during the cell cycle in hESCs.
To validate these results, we carried out ChIP-qPCR analysis
from G2-, M-, and G1-phase cells isolated from asynchronous
hESC cultures (not nocodazole treated) using FACS. Because only
limited numbers of mitotic cells are present in asynchronous cul-
tures and H3K27me3 does not vary significantly across the cell
cycle, we evaluated H3K4me3 levels for selected genes representa-
tive of each of the three bivalency categories. Total levels of histone
H3were assessed to control for possible local variations in nucleo-
somal density. These experiments corroborated that, in asynchro-
nous cultures, the ME TBX1 and TLX2 genes are modified with
H3K4me3 exclusively during mitosis, and H3K4me3 levels in the
Ub bivalent TBC1D20 and PPP1RA1 genes do not vary signifi-
cantly across the cell cycle. Moreover, genes representative of the
G1-dep category, the COL1A1 and FOXJ1 genes, show somewhat
reduced levels of H3K4me3 in G1 (Fig. 2A and E; see also Fig. S3A
in the supplemental material).
Taken together, these results reveal unexpected cell cycle-de-
pendent variations in the histone modification landscape that ex-
pose previously unknown categories of bivalent genes.
Bivalent genes enrichedwithH3K4me3duringmitosis expe-
rience the strongest upregulation at the onset of hESC differen-
tiation. To understand how the dynamic regulation of H3K4me3
during the pluripotent cell cycle influences transcription of biva-
lent genes during lineage commitment, we used high-throughput
RNA sequencing (RNA-seq). RNA expression levels were ana-
lyzed in hESCs before or after induction of retinoic acid (RA)
differentiation. As in previous reports (7–9), we found that in
undifferentiated hESCs, bivalent genes are either repressed or ex-
pressed at very low levels (Fig. 3A). Interestingly, genes in the ME
class were the most repressed, whereas those in the G1-dep group
were the least repressed (Fig. 3A). Consistently, genes in the ME
class displayed the highest levels of the repressive H3K27me3
mark, and G1-dep genes showed the highest average levels of
H3K4me3 (Fig. 2C). As expected, after inducing differentiation
with RA (10 M, 5 days), we observed downregulation of the
pluripotencymarkerOCT4 and upregulation of the early ectoder-
mal marker PAX6 (Fig. 4A and B) (8). Accordingly, the epigenetic
status of theOCT4promoter changed to a repressed form,with no
H3K4me3 and high H3K27me3 (see Fig. S4D in the supplemental
material). Likewise, the PAX6 promoter switched from a bivalent,
ME state to an active configuration rich in H3K4me3, with very
little H3K27me3 (see Fig. S4D). Compared with undifferentiated
hESCs, the PAX6-expressing cells (PAX6 cells) displayed signifi-
cant differential expression of 546 genes (P  0.05) (Fig. 3B).
Among these, 138 upregulated genes were bivalent (Fig. 3D). The
ME category had the highest proportion of upregulated bivalent
genes after RA induction. More importantly, most of these up-
regulated genes encode transcription factors with developmental
functions (Fig. 3D), and they displayed the largest changes in RNA
levels in response to RA treatment (Fig. 3C). In contrast, although
many genes in the G1-dep and Ub categories were significantly
upregulated, changes in their expression were smaller (Pearson’s
correlation coefficient R  0.661 for ME genes, R  0.876 for
G1-dep genes, and R  0.825 for Ub genes) (Fig. 3E). These
changes are consistent with the H3K4me3 and H3K27me3 ChIP-
seq profiles seen in bivalent genes before and after induction of
hESC differentiation (see Fig. S4C).
Taken together, these results indicate that bivalent genes which
accumulate H3K4me3 modifications during mitosis in pluripo-
tent cells experience more pronounced upregulation at the onset
of differentiation. This suggests that these genes are controlled by
a distinct mechanism of mitotic chromatin regulation that allows
transcriptional activation in response to differentiation cues.
The pluripotent H3K4me3 landscape becomes cell cycle in-
dependent upon cell fate commitment. To address whether the
cell cycle-dependent, histone modification patterns observed in
hESCs are retained in nonpluripotent cells, we generated ChIP-
seq libraries for H3K4me3 and H3K27me3 histone modifications
fromRA-differentiated hESCs (PAX6 cells) synchronized and iso-
lated by FACS at the G2, M, or G1 phase of the cell cycle (see Fig.
S4A in the supplementalmaterial). Comparison of theH3K4me3/
H3K27me3 ChIP-seq profiles obtained in hESCs and PAX6 cells
revealed that, althoughnumerous genes lost bivalency after induc-
tion of differentiation, many others remained bivalent (Fig. 4C
and E; see also Fig. S4C and D). This result was consistent with
upregulation of only a fraction of bivalent genes after induction of
differentiation (Fig. 3B) and also with reports that the gain or loss
of bivalency depends onwhether or not genes are activated during
a specific lineage-determination process (27, 28).
Importantly, as in ESCs, the average level of H3K27me3 in
PAX6 cells remained relatively constant through the G2-M-G1
transition, which suggests that the cell cycle-related regulation of
H3K27me3 is similar in hESCs before and after the onset of dif-
ferentiation (Fig. 4C and E; see also Fig. S4B in the supplemental
material). In contrast, the H3K4me3 enrichments became cell cy-
cle independentwhen cells began to differentiate—constant levels
of H3K4me3 were observed across the different categories of bi-
valent genes, during theG2-M-G1 transition in PAX6 cells (Fig. 4C
to E). Of note, although our initial analysis showed higher levels of
the H3K4me3mark during G2, these enrichments were abrogated
when different types of data normalization were applied (read
number versus MA-norm-like scaling normalization) (Fig. 4D).
Together, these results indicate that regulation of H3K4me3 at
genes that remain bivalent after the onset of differentiation (PAX6
cells) is cell cycle independent and, furthermore, that the cell cy-
cle-dependent regulation of H3K4me3 modification within biva-
lent domains is unique to the pluripotent state. This finding is
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consistent with a model in which active accumulation of
H3K4me3 during mitosis prepares repressed bivalent genes for
activation in response to differentiation cues at the start of the G1
phase. If those cues do notmaterialize, H3K4me3 is removed dur-
ing G1.
Cell cycle-dependent variation of H3K4me3 correlates with
sequential recruitment of KDM5A,MLL1/2, andWDR5.To un-
derstand the dynamic regulation of H3K4me3 levels in bivalent
genes, we assessed the chromatin occupancy of proteins with
H3K4me3 regulatory activity during the pluripotent cell cycle.
First, because MLL has H3K4 methyltransferase activity and re-
mains associated with chromatin during mitosis (20), we used
ChIP-qPCR to evaluate its interaction with a representative set of
bivalent gene promoters during the G2-M-G1 transition in unsyn-
chronized hESCs (Fig. 5A). We detected significant MLL binding
on promoters of ME genes only during mitosis. Promoters of G1-
dep genes showed modest levels of MLL binding that remained
constant during G2 and mitosis and decreased significantly in G1.
Consistent with expectations, the MLL binding pattern for Ub
gene promoters was constant during theG2-M-G1 transition. Fur-
thermore, because it was recently shown that MLL2 is the main
lysine methyltransferase responsible for H3K4me3 on bivalent
genes in mouse ESCs (29, 30), we also assessed the chromatin
occupancy of MLL2. Although the binding of MLL2 was modest
among the genes evaluated here, the trendswere similar to those of
MLL cell cycle-dependent binding. Likewise, WDR5, a subunit of
the MLL methyltransferase complex that is essential for MLL ac-
tivity and critical for maintaining ESC self-renewal (3, 31), occu-
pied ME and G1-dep gene promoters during G2 and mitosis only,
becoming completely dissociated during G1. Interestingly, amod-
est but significant enrichment of WDR5 binding was observed
during mitosis in ME gene promoters. More importantly, how-
ever, no significant cell cycle variation in WDR5 binding to Ub
gene promoters was detected.
These results suggest that MLL/WDR5 proteins associate with
bivalent gene promoters in a cell cycle-dependent manner that
FIG 3 Bivalent genes enriched with H3K4me3 during mitosis experience the strongest upregulation at the onset of hESC differentiation. (A) Box plots for RNA
expression (RNA-seq) of bivalent genes in unsynchronized hESCs. The boxes represent the interquartile range (25th to 75th percentiles) for expression of
bivalent genes in the indicated categories; the line in the middle of the box represents the median value. (B) Scatter plot demonstrating relative gene expression
in hESCs versus PAX6-expressing cells. Genes significantly upregulated or downregulated (P 0.05) in RA-treated, PAX6-expressing cells are highlighted. Genes
that remain unchanged are in gray. (C) Heat map of RNA expression levels for bivalent genes upregulated in PAX6 cells. Expression values are presented as
fragments per kilobase per millionmapped reads (FPKM) on a log2 scale. (D) List of bivalent genes significantly upregulated in PAX6 cells, displayed for each of
the categories of bivalent genes. (E) Scatter plots of RNA expression in hESCs versus PAX6 cells. Expression profiles are displayed for each category of bivalent gene as
fragments per kilobase per millionmapped reads (FPKM) on a log2 scale. Pearson correlation coefficients are displayed in the upper left corner of each plot.
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correlates with H3K4me3 enrichment in G2 and mitosis (Fig. 2).
However, they do not explain the reduced H3K4me3 levels ob-
served in G1 phase.We therefore evaluated KDM5A, a member of
the H3K4 di-/tridemethylase family involved in repression of
many developmental genes in ESCs (32). Using asynchronous
hESC cultures, we found that levels of KDM5Aweremodestly but
significantly enriched in G1 near ME and G1-dep gene promoters,
which is consistent with the variations in H3K4me3 observed
among these genes during the cell cycle (Fig. 5A). Strikingly, the
chromatin occupancy of KDM5A onUb category gene promoters
was also significantly increased during G1 (Fig. 5A). This finding
was unexpected because of the constantH3K4me3 levels observed
among Ub gene promoters through the cell cycle. However, it is
consistent with reports that H3K27me3 facilitates KDM5A re-
cruitment to chromatin (4, 32) and could explain the slight in-
crease in global H3K27me3 levels that we observed in hESCs after
mitosis (Fig. 1D). This mechanism would reinforce repression of
bivalent genes in pluripotent cells during G1 phase in the absence
of differentiation signals and would be relevant when enzymes
with H3K4 methyltransferase activity are not present.
Overall, these results indicate that the methylase/demethylase
machinery involved in regulating H3K4me3 levels in hESCs is
recruited differentially to bivalent genes in a cell cycle-dependent
manner (Fig. 5B). Furthermore, they suggest that similar, related
mechanisms may be responsible for the H3K4me3 profiles ob-
served on all bivalent genes.
Disruption of MLL1/2 trimethylase activity abrogates
H3K4me3mitotic enrichment anddelays expressionof bivalent
genes upon induction of cellular differentiation.To further un-
derstand the role of H3K4me3 enrichment in bivalent genes
during mitosis in pluripotent cells, we assessed the biological
consequences of disrupting the activity of the H3K4 trimethy-
lases MLL1/2. Since the genetic ablation of components of the
COMPASS complex, including MLL, DPY30, or DWR5 pro-
teins, not only reduces H3K4me3 levels on target genes but also
affects the self-renewal capabilities of pluripotent cells (20, 31,
33), we conducted our experiments using less disruptive con-
ditions. We took advantage of two recently developed chemical
agents that inhibit MLL1/2 activity, Mi-2 and MM-102. These
small nonpeptide molecules decrease H3K4me3 levels on genes
by disrupting the interaction between MLL-menin and MLL-
WDR5, respectively (34, 35) (Fig. 6A).
Our results show that in hESCs, a 24-h treatment with these
inhibitors drastically reduces the levels of H3K4me3 on bivalent
genes in mitotic cell-enriched (nocodazole-treated) cultures
(Fig. 6B andD), without causingmajormorphological alterations
FIG 4 The pluripotent H3K4me3 landscape becomes cell cycle independent upon cell fate commitment. (A) Immunofluorescencemicroscopy of asynchronous
undifferentiated (top) or differentiated (bottom)hESC cultures (retinoic acid, 10M,5days). Cells were stained for nuclearDNA (DAPI, blue),OCT4 (red), and
PAX6 (green). (B) Expression of the pluripotency marker OCT4 and the early differentiation marker PAX6 was analyzed by Western blotting before and after
retinoic acid (RA) treatment to induce hESC differentiation. (C) Heat map of H3K27me3 andH3K4me3 profiles observed in PAX6-expressing RA-treated cells.
The plot shows ChIP-seq enrichments/input in a log2 scale for bivalent genes defined in hESCs. (D) Effect of data normalization on the H3K4me3 ChIP-seq
enrichments observed during the G2-M-G1 transition in undifferentiated and differentiated hESCs. The left panel shows the enrichment profiles after read-
number normalization. The right panel shows the enrichment profiles obtained after MA-like data normalization. Note that enrichment of H3K4me3 observed
in the G2 phase of PAX6-expressing cells is not seen when data are analyzed using MA-like normalization. (E) ChIP-seq enrichment at select bivalent genes that
exhibit loss of cell cycle-dependent H3K4me3 patterns after induction of differentiation. Shaded areas indicate bivalent domains. As with the undifferentiated
hESCs, the ChIP-seq libraries for H3K4me3 andH3K27me3 used in panel C were generated from synchronized PAX6	 cells sorted into G2, M, and G1 phases of
the cell cycle.
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(DMSO versus Mi-2/MM-102, 20 M for 24 h) (see Fig. S5 in the
supplemental material). These results further confirmed that
H3K4me3 levels are increased during mitosis on certain bivalent
genes, such as the PAX6 and HOXA4 genes (from the ME cate-
gory), and that this phenomenon is dependent on the activity of
MLL1/2 complexes (Fig. 6D). As expected, genes from the G1-dep
(COL1A1 gene) and ubiquitous (PPP1RA1 gene) categories did
not display H3K4me3 enrichment after synchronization of the
cells inmitosis. However, after treatment withMLL1/2 inhibitors,
H3K4me3 levels on these genes were reduced (Fig. 6D). Consis-
tent with the distribution of H3K4me3 near the TSSs of genes, the
effect of the inhibitors was observed in regions proximal to the
TSSs of all the genes analyzed (PAX6, HOXA4, COL1A1,
PPP1RA1, and CDC25A genes) but not on a region distal to the
TSS (distal CDC25A gene [Fig. 6D]).
Once we established that the acute treatment of human ESCs
with a combination of inhibitors successfully inhibited MLL1/2
activity and partially or completely reduced the levels of
H3K4me3 on bivalent genes, we assessed the effect on expression
of bivalent genes during differentiation. To do this, we incubated
cells for 24 h with Mi-2 or MM-102 (20 M). Subsequently, the
MLL1/2 inhibitors were withdrawn; cells were washed with fresh
medium, resuspended, and plated as single cells in medium con-
taining RA (1M); and then cells were incubated for 24 h (Fig. 6C).
FIG5 Cell cycle-dependentH3K4me3 variation in ESCs correlates with sequential recruitment of KDM5A,MLL1/2, andWDR5 to bivalent gene promoters. (A)
ChIP-qPCR analysis of unsynchronized hESCs sorted at specific phases of the cell cycle, showing the sequential binding of KDM5A and MLL1/2 and the MLL
partner WDR5 to bivalent genes. Results are expressed as percent input and are normalized to the IgG control (n 3 for KDM5A and MLL1; n 2 for MLL2
andWDR5). Ordinary one-way analysis of variance followed by Tukey’s test for multiple comparisons was performed. *, P 102; **, P 103; ***, P 104;
****, P 105; ns, not significant. (B) Summary of the cell cycle-dependent changes observed on histone H3 lysine 4 (K4) in the context of bivalent domains.
For simplicity, H3K27me3 is not shown. Sizes of the circles and ovals denote the levels of histone marks or protein enrichments around the TSSs (arrows) of
bivalent genes.
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FIG 6 Disruption of MLL1/2 trimethylase activity abrogates H3K4me3 mitotic enrichment and delays expression of bivalent genes upon induction of cellular
differentiation. (A) MLL1/2 inhibitors MM-102 and Mi-2 disrupt the interaction of MLL proteins with WDR5 and menin, respectively. (B) Summary of the
strategy used to analyze the effect ofMLL1/2 inhibitors onH3K4me3 levels inH9 hESCs. Briefly, 2 days after passaging, cells were incubated inmTeSR-1medium
containing Mi-2/MM-102 (20 M each) for 8 h, followed by 16 h of culture with nocodazole (200 ng/ml) plus Mi-2/MM-102 (20 M each). Cells were then
collected, fixed, and subjected to the ChIP protocol. (C) Strategy used to address the effect of blockingMLL1/2 activity before induction of differentiation in H9
hESCs. Briefly, 2 days after passaging, cells were preincubated in E8 medium containing 20 M (each) Mi-2 and MM-102 for 24 h. Subsequently, single-cell
suspensions were prepared, and 8 105 cells were seeded in E6medium containing 1Mretinoic acid (RA); 24 h later, total RNAwas extracted. (D) ChIP-qPCR
analysis of the H3K4me3 levels in hESCs synchronized in mitosis with or without MLL1/2 inhibitors. DMSO, cells treated with DMSO only; Noc, cells blocked
in mitosis with nocodazole; Noc	MLL Inh, cells blocked in mitosis with nocodazole in the presence of Mi-2 and MM-102 (20 M each). Values for percent
input are normalized to the IgG control (n 2). One-way analysis of variance followed by Tukey’s test for multiple comparisons was performed. *, P 102;
****, P  105; ns, not significant. (E) Reverse transcription-qPCR analysis of RNA expression levels for bivalent genes after induction of differentiation in
unsynchronizedH9ES cells pretreatedwithMLL inhibitors. Differentiationwas induced using E6medium containing 1MRAper 24 h.DMSO, cells pretreated
with DMSO only; MLL Inh, cells pretreated withMi-2 andMM-102 (20Meach) for 24 h. Unpaired parametric t test withWelch’s corrections was performed.
Two-tailed P values were calculated. *, P 102; **, P 103; ***, P 104; ns, not significant. Log2 RNA levels were normalized against HPRT1 RNA levels
and expressed as fold change between undifferentiated and differentiated cells. (F) Summary of the transcriptional outcome of decreasing the mitotic H3K4me3
enrichment in hESCs prior to induction of cellular differentiation. Sizes of the green circles and ovals denote levels of histone marks or protein enrichments
around the TSSs (arrows) of bivalent genes. The thickness and number of arrows represent levels of gene expression.
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Using qPCR, we found that, in response to RA induction, the
expression of ME-category bivalent genes, the PAX6, HOXA4,
GATA6, andMEIS2 genes, was reduced or delayed in cells that had
been preincubatedwithMLL1/2 inhibitors, compared to differen-
tiated cells that were not exposed to the MLL1/2 inhibitors (Fig.
6E). Interestingly, inhibition of MLL1/2 prior to the induction of
differentiation also delayed the differentiation-dependent repres-
sion of genes that are expressed in the pluripotent state (NANOG
andMIXL1 genes) (Fig. 6E). Importantly, treatment withMLL1/2
inhibitors did not affect the expression of control genes, the
SIP1, glyceraldehyde-3-phosphate dehydrogenase (GAPDH), and
HRPT1 genes, indicating that these inhibitors do not alter gene
expression globally. This is consistent with the fact that in ESCs,
MLL1/2 predominantly catalyze trimethylation of H3K4 on biva-
lent genes (29, 30).
Together, these results reveal that in hESCs, the inhibition of
MLL1/2 activity is sufficient to reduce the levels of H3Kme3 on
bivalent genes, which correlates with a delay in the expression of
bivalent genes after induction of cellular differentiation (Fig. 6F).
DISCUSSION
The current consensus is that most bivalent genes are largely re-
pressed in pluripotent cells (7, 28, 33) but can rapidly respond to
initiators of differentiation by turning on expression in the G1
phase of the cell cycle (36). Because the G1 phase in pluripotent
hESCs is considerably shorter than that in differentiating cells, it is
reasonable to assume that a unique mechanism, active during the
M-G1 transition, is required for cells to mount such a rapid re-
sponse. In this context, a highly dynamic bivalent landscape may
be critical for generating local chromatin conformations that fa-
cilitate rapid unfolding of mitotic chromosomes and expedite
transcriptional activation in response to differentiation cues dur-
ing G1. In this model, genes required for early differentiation are
poised for expression only during a very brief window of time, in
the context of a transcriptionally unfavorable mitotic environ-
ment that prevents unnecessary gene expression. Accordingly, in
the absence of differentiation cues, the drastic reduction in
H3K4me3 levels observed during G1 phase would prevent leaky
transcription during this phase of the cell cycle when chromatin
becomesmore accessible. The fact that these histonemodification
patterns become cell cycle independent after induction of differ-
entiation further supports this scenario and implies that a cell
cycle-dependent epigenetic landscape is instrumental in main-
taining chromatin architecture plasticity in pluripotent cells but
not in committed cells. This is consistent with the finding of Blo-
bel et al. that H3K4me3 remains constant during the G2-M-G1
transition in HeLa cells (20). The lengthening of the cell cycle
associated with lineage commitment (21, 37) would provide ade-
quate time for cell cycle-independent, expression-regulation
mechanisms.
This interpretation is consistent with a recent report from the
Vallier lab, documenting that developmental genes not expressed
in undifferentiated hESCs become actively transcribed during G1
phase in response to differentiation cues (36). There is, however, a
conflicting recent study reporting that developmental genes are
expressed during the G1 phase of undifferentiated hESCs (38).
Importantly, though, this study did not include a selection step to
isolate highly pluripotent cells.
Our results reveal the existence of new categories of bivalent
domains in ESCs that are associated with genes that have specific
cellular functions and expression patterns before and after the
onset of differentiation. Importantly, by using a representative set
of bivalent genes, we showed that similar cell cycle-dependent
histone modification profiles are seen in hESCs purified at G2,
mitosis, and G1 with or without prior chemical synchronization
and that the epigenetic status of these genes correlates with the
sequential recruitment of the H3K4methylase/demethylase enzy-
maticmachinery to chromatin. This is consistent with the fact that
the inhibition of MLL1/2 activity decreases the levels of
H3K4me3, implying that, after disruption of trimethylase activity,
histone demethylases are ready to take over. This mechanism
would be important to maintain the dynamic regulation of the
H3K4me3 histone mark during the cell cycle.
Of note, hESCs treated to inhibit MLL1/2 activity proliferated
at a lower rate than control cells (data not shown); this is consis-
tent with a study reporting that human leukemia cells treated with
Mi-2 are arrested in the G1 phase of the cell cycle (35). This obser-
vation suggests that a properly functioning MLL1/2 complex is
critical to sustain self-renewal and that the deteriorated self-re-
newing capability observed in ESCs after knockdown of compo-
nents of the COMPASS complex may be due more to a lack of
H3K4 methylase activity than to the physical absence of these
proteins (20, 31, 33). Although inhibition ofMLL1/2 trimethylase
activity may alter the expression profile of genes necessary for
self-renewal, it is also possible that normal patterns of H3K4me3
on bivalent chromatin are required for cells to properly progress
through the cell cycle. This is important because it would provide
a plausible explanation for the existence of bivalent chromatin
domains that do not lose H3K4me3 during the pluripotent G1
phase (genes in the ubiquitously bivalent category). Whether
these bivalent domains are important for cell cycle progression,
perhaps by establishing the right conditions for proper DNA rep-
lication, is something that should be evaluated in the future.
Importantly, as Pauklin and Vallier showed (36), hESCs re-
spond to differentiation cues during the G1 phase of the cell cycle.
Therefore, it should not be surprising that delaying or arresting
G1-phase progression could have consequences for the timing of
cellular differentiation. In this regard, we have shown that de-
creasing the levels of H3K4me3 on bivalent genes prior to induc-
tion of differentiation delayed the expression of critical develop-
mental bivalent genes. This reduced expression seems to be a
consequence of impeding the differentiation process, as suggested
by the delayed repression of the NANOG gene observed in hESCs
induced to differentiate after preinhibition of the MLL1/2 com-
plex.
Overall, our findings strikingly reveal that, at least in pluripo-
tent cells, chromatin structure associated with bivalent genes is
not static but dynamically regulated during the cell cycle. The cell
cycle-dependent control of epigenetic modification in bivalent
domains represents a novel dimension to chromatin regulation
that advances understanding of how hESC identity is maintained.
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